Concepts (43)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenergic beta-Antagonists | 1 | 2025 | 216 | 0.210 |
Why?
|
| Chromosomes, Human, Y | 1 | 2023 | 52 | 0.200 |
Why?
|
| Turner Syndrome | 1 | 2023 | 44 | 0.200 |
Why?
|
| Ventricular Function, Left | 1 | 2025 | 548 | 0.180 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2023 | 127 | 0.170 |
Why?
|
| Graphite | 1 | 2021 | 16 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 219 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2025 | 998 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 970 | 0.120 |
Why?
|
| Neoplasms | 1 | 2021 | 2994 | 0.060 |
Why?
|
| Karyotype | 1 | 2023 | 30 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 709 | 0.050 |
Why?
|
| Karyotyping | 1 | 2023 | 308 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2023 | 154 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2025 | 540 | 0.050 |
Why?
|
| Mosaicism | 1 | 2023 | 247 | 0.040 |
Why?
|
| Quantum Dots | 1 | 2021 | 16 | 0.040 |
Why?
|
| Hyaluronan Receptors | 1 | 2021 | 64 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1262 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2021 | 76 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 108 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2023 | 455 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 107 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 436 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2023 | 818 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2021 | 288 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 688 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 802 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 567 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6168 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 2827 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 5048 | 0.030 |
Why?
|
| Prognosis | 1 | 2023 | 4866 | 0.020 |
Why?
|
| Heart Failure | 1 | 2025 | 2325 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1876 | 0.020 |
Why?
|
| Humans | 4 | 2025 | 130534 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1814 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12854 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 10036 | 0.020 |
Why?
|
| Adolescent | 1 | 2023 | 20879 | 0.010 |
Why?
|
| Child | 1 | 2023 | 26237 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 31121 | 0.010 |
Why?
|
| Female | 1 | 2023 | 70563 | 0.010 |
Why?
|